Profound Medical Corp.PROFNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-2.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -99.90% |
| Q3 2025 | -20.37% |
| Q2 2025 | 13.58% |
| Q1 2025 | -65.46% |
| Q4 2024 | 164.76% |
| Q3 2024 | 77.56% |
| Q2 2024 | 5.40% |
| Q1 2024 | -71.59% |
| Q4 2023 | 301.65% |
| Q3 2023 | -2.91% |
| Q2 2023 | 3.36% |
| Q1 2023 | -17.86% |
| Q4 2022 | -19.54% |
| Q3 2022 | 27.25% |
| Q2 2022 | -12.36% |
| Q1 2022 | -18.63% |
| Q4 2021 | 21.50% |
| Q3 2021 | 38.73% |
| Q2 2021 | -11.31% |
| Q1 2021 | 3.83% |
| Q4 2020 | 47.65% |
| Q3 2020 | 15.71% |
| Q2 2020 | -17.73% |
| Q1 2020 | 7.23% |
| Q4 2019 | 35.06% |
| Q3 2019 | 5.92% |
| Q2 2019 | 183.11% |
| Q1 2019 | -50.73% |
| Q4 2018 | -27.33% |
| Q3 2018 | -19.12% |
| Q2 2018 | 46.18% |
| Q1 2018 | -13.47% |
| Q4 2017 | 6.94% |
| Q3 2017 | -6.74% |
| Q2 2017 | 18.69% |
| Q1 2017 | 14.94% |
| Q4 2016 | 52.79% |
| Q3 2016 | 6.01% |
| Q2 2016 | 5.26% |
| Q1 2016 | 43.45% |